Måndag 8 Juni | 23:51:37 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-10-22 08:00 Kvartalsrapport 2026-Q3
2026-07-16 08:00 Kvartalsrapport 2026-Q2
2026-05-13 - X-dag ordinarie utdelning BONEX 0.00 SEK
2026-05-12 - Årsstämma
2026-04-22 - Kvartalsrapport 2026-Q1
2026-02-24 - Bokslutskommuniké 2025
2025-10-23 - Kvartalsrapport 2025-Q3
2025-07-15 - Kvartalsrapport 2025-Q2
2025-05-28 - X-dag ordinarie utdelning BONEX 0.00 SEK
2025-05-27 - Årsstämma
2025-04-24 - Kvartalsrapport 2025-Q1
2025-02-25 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-11 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning BONEX 0.00 SEK
2024-05-16 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning BONEX 0.00 SEK
2023-05-17 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning BONEX 0.00 SEK
2022-05-19 - Årsstämma
2022-05-04 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning BONEX 0.00 SEK
2021-05-20 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-17 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-05-20 - X-dag ordinarie utdelning BONEX 0.00 SEK
2020-05-19 - Årsstämma
2020-05-08 - Kvartalsrapport 2020-Q1
2020-02-26 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-25 - Kvartalsrapport 2019-Q2
2019-05-15 - X-dag ordinarie utdelning BONEX 0.00 SEK
2019-05-14 - Årsstämma
2019-05-02 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-07 - Kvartalsrapport 2018-Q3
2018-07-26 - Kvartalsrapport 2018-Q2
2018-05-23 - X-dag ordinarie utdelning BONEX 0.00 SEK
2018-05-22 - Årsstämma
2018-05-04 - Kvartalsrapport 2018-Q1
2018-02-20 - Bokslutskommuniké 2017
2017-11-02 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Bonesupport är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av biokeramiska implantat för benreparation och rekonstruktion. Bolagets produkter riktar sig till kirurger och sjukvårdsinstitutioner. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. Bonesupport grundades år 1999 och har sitt huvudkontor i Lund.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-06-08 13:56:00

The Board of Directors of BONESUPPORT HOLDING AB (“BONESUPPORT”) has today resolved to utilize one of the two authorizations to acquire own ordinary shares granted by the Annual General Meeting on 12 May 2026. The Board of Directors has resolved to acquire a maximum of 373,320 ordinary shares for a total amount of maximum SEK 100 million for the purpose of ensuring BONESUPPORT’s obligations arising from the long-term share savings program LTI 2026 as resolved by the Annual General Meeting on 12 May 2026.

The acquisition of shares will be carried out in accordance with the Market Abuse Regulation (EU) 596/2014 ("MAR") and the European Commission's Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The acquisition of shares will be managed by DNB Carnegie Investment Bank AB that will make its own trading decisions regarding the timing of the acquisitions independently of BONESUPPORT.

The following terms and conditions apply to the acquisitions of shares:

  • Acquisition of shares shall be made on Nasdaq Stockholm in accordance with Nasdaq Stockholm’s Main Market Rulebook for Issuers of Shares, MAR and the Safe Harbour Regulation.
  • Acquisitions of shares may be made on one or several occasions and shall commence no earlier than 9 June 2026 and shall end no later than 9 July 2026.
  • A maximum of 373,320 shares may be acquired for a total amount of up to SEK 100 million for the purpose of ensuring BONESUPPORT’s obligations arising from LTI 2026. 
  • Acquisitions shall be made in compliance with the volume and price restrictions set out in Nasdaq Stockholm’s Main Market Rulebook for Issuers of Shares and in the Safe Harbour Regulation, and shall not be made at a price lower than the lowest price at which an independent purchase may take place.
  • Payment for acquired shares shall be made in cash.

As per 8 June 2026, the total number of shares in BONESUPPORT HOLDING AB is 66,764,350, of which 65,859,195 are ordinary shares and 905,155 are Series C shares. BONESUPPORT HOLDING AB holds no ordinary shares and 905,155 Series C shares as per the same date.